Tafamidis treats transthyretin amyloid cardiomyopathy
(HealthDay)—In patients with transthyretin amyloid cardiomyopathy, treatment with tafamidis reduces all-cause mortality and cardiovascular-related hospitalizations versus placebo, according to a study published in the Sept. ...
Sep 18, 2018
0
1